98 related articles for article (PubMed ID: 29945702)
21. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer.
Shigematsu Y; Hanagiri T; Shiota H; Kuroda K; Baba T; Mizukami M; So T; Ichiki Y; Yasuda M; So T; Takenoyama M; Yasumoto K
Lung Cancer; 2010 Apr; 68(1):105-10. PubMed ID: 19545928
[TBL] [Abstract][Full Text] [Related]
22. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma].
Chen QY; Jiang ZY; Wu LJ; Zhang BY; Lu GH; Zhou JY
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):278-82. PubMed ID: 20510079
[TBL] [Abstract][Full Text] [Related]
23. [Expression of KIF23 and Its Prognostic Role in Non-small Cell Lung Cancer:
Analysis Based on the Data-mining of Oncomine].
Ye L; Li H; Zhang F; Lv T; Liu H; Song Y
Zhongguo Fei Ai Za Zhi; 2017 Dec; 20(12):822-826. PubMed ID: 29277180
[TBL] [Abstract][Full Text] [Related]
24. Low expression of olfactomedin 4 correlates with poor prognosis in smoking patients with non-small cell lung cancer.
Su W; Luo L; Wu F; Lai Z; Li X; Xie Z; Tang Z; Yang Z; Liang R
Hum Pathol; 2015 May; 46(5):732-8. PubMed ID: 25771901
[TBL] [Abstract][Full Text] [Related]
25. [Expression of autophagy-related genes Beclin1 and MAPLC3 in non-small cell lung cancer].
Liu Q; Wang JJ; Pan YC; Meng LF; Zhan X; Zheng QF
Ai Zheng; 2008 Jan; 27(1):25-9. PubMed ID: 18184459
[TBL] [Abstract][Full Text] [Related]
26. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
[TBL] [Abstract][Full Text] [Related]
27. GSK-3β inhibits autophagy and enhances radiosensitivity in non-small cell lung cancer.
Ren J; Liu T; Han Y; Wang Q; Chen Y; Li G; Jiang L
Diagn Pathol; 2018 May; 13(1):33. PubMed ID: 29793508
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of LINC01510 predicts poor prognosis and promotes malignant progression in human non-small cell lung cancer.
Li J; Wei L
Biomed Pharmacother; 2019 Jan; 109():519-529. PubMed ID: 30399588
[TBL] [Abstract][Full Text] [Related]
29. The clinical significance of transforming acidic coiled-coil protein 3 expression in non-small cell lung cancer.
Jiang F; Kuang B; Que Y; Lin Z; Yuan L; Xiao W; Peng R; Zhang X; Zhang X
Oncol Rep; 2016 Jan; 35(1):436-46. PubMed ID: 26531241
[TBL] [Abstract][Full Text] [Related]
30. Correlation Between MMP-7 and bFGF Expressions in Non-small Cell Lung Cancer Tissue and Clinicopathologic Features.
Xiao XY; Lang XP
Cell Biochem Biophys; 2015 Nov; 73(2):427-432. PubMed ID: 27352333
[TBL] [Abstract][Full Text] [Related]
31. [Relationships among expressions of hTERT, MDR1, MRP mRNA, and C-myc protein in non-small cell lung cancer].
Li L; Xiong YY; Liu L; Chen TX; Yao XF; Wang YW
Ai Zheng; 2005 Jan; 24(1):53-7. PubMed ID: 15642200
[TBL] [Abstract][Full Text] [Related]
32. Autophagy and Bcl-2/BNIP3 death regulatory pathway in non-small cell lung carcinomas.
Karpathiou G; Sivridis E; Koukourakis M; Mikroulis D; Bouros D; Froudarakis M; Bougioukas G; Maltezos E; Giatromanolaki A
APMIS; 2013 Jul; 121(7):592-604. PubMed ID: 23216071
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of PAFAH1B1 is associated with tumor metastasis and poor survival in non-small cell lung cancer.
Lo FY; Chen HT; Cheng HC; Hsu HS; Wang YC
Lung Cancer; 2012 Sep; 77(3):585-92. PubMed ID: 22749159
[TBL] [Abstract][Full Text] [Related]
34. SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma.
Glatzel-Plucinska N; Piotrowska A; Grzegrzolka J; Olbromski M; Rzechonek A; Dziegiel P; Podhorska-Okolow M
Anticancer Res; 2018 Feb; 38(2):723-736. PubMed ID: 29374696
[TBL] [Abstract][Full Text] [Related]
35. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
37. Integrated analysis of the prognostic value of TP53 dependent etoposide-induced gene 24 in non-small cell lung cancer.
Wang M; Li P; Wan R; Liu X
Biomed Pharmacother; 2019 Apr; 112():108590. PubMed ID: 30784913
[TBL] [Abstract][Full Text] [Related]
38. Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.
Spandidos DA; Zakinthinos S; Petraki C; Sotsiou F; Yiagnisis M; Dimopoulos AM; Roussos C; Field JK
Anticancer Res; 1990; 10(5A):1105-14. PubMed ID: 2173469
[TBL] [Abstract][Full Text] [Related]
39. Wnt1 overexpression associated with tumor proliferation and a poor prognosis in non-small cell lung cancer patients.
Nakashima T; Liu D; Nakano J; Ishikawa S; Yokomise H; Ueno M; Kadota K; Huang CL
Oncol Rep; 2008 Jan; 19(1):203-9. PubMed ID: 18097596
[TBL] [Abstract][Full Text] [Related]
40. AP‑4 predicts poor prognosis in non‑small cell lung cancer.
Gong H; Han S; Yao H; Zhao H; Wang Y
Mol Med Rep; 2014 Jul; 10(1):336-40. PubMed ID: 24804973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
